On March 14, 2023, the FDA amended the emergency use authorization of the updated (bivalent) Pfizer-BioNTech COVID-19 vaccine to include a single booster dose of the vaccine in children 6 months – 4 years old.
The state's decision to match the Medicaid reimbursement rate for important services, such as routine health examinations, empowers doctors to take on more Medicaid recipients.
